Skip to main content
BrainCited

Omega-3 Fatty Acids (DHA/EPA) के लिए Age-Related Cognitive Decline

A

A systematic review of 58 studies found each 2,000 mg/day of omega-3 showed significant improvements in attention, perceptual speed, language, and primary memory. Research suggests a non-linear dose-response with optimal effects at moderate doses under 1,700 mg/day.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

निष्कर्ष

A systematic review of 58 studies found each 2,000 mg/day of omega-3 showed significant improvements in attention, perceptual speed, language, and primary memory. Research suggests a non-linear dose-response with optimal effects at moderate doses under 1,700 mg/day.

Key Study Findings

Systematic Review
Impact of Vegan and Vegetarian Diets on Neurological Health: A Critical Review.
Dose: None बनाम: None Outcome: Neurological health outcomes प्रभाव: None None

जनसंख्या: None

Review
Neuroprotective Role of Omega-3 Fatty Acids: Fighting Alzheimer's Disease.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: None

Review
Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease.
Dose: Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d बनाम: None Outcome: Cognitive decline in AD प्रभाव: None None

जनसंख्या: Alzheimer's disease patients

Review
Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: None

Review
Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: None

In Vitro
Multiplatform Lipid Analysis of the Brain of Aging Mice by Mass Spectrometry.
Dose: None बनाम: None Outcome: Age-dependent brain lipid changes प्रभाव: None None

जनसंख्या: Mice: adult (3-4mo), middle-aged (10mo), old (19-21mo)

Key Statistics

58

अध्ययन

12000

प्रतिभागी

Positive

A

ग्रेड

Referenced Papers

Nutrients 2025 22 उद्धरण
Molecules (Basel, Switzerland) 2025 10 उद्धरण
Journal of proteome … 2025 8 उद्धरण
Journal of Alzheimer's … 2025 3 उद्धरण
Nutrients 2025 2 उद्धरण
Handbook of experimental … 2025 1 उद्धरण
Current opinion in … 2023 58 उद्धरण
Alzheimer's & dementia … 2023 7 उद्धरण
Nutrients 2022 76 उद्धरण
International journal of … 2022 23 उद्धरण
Biomolecules 2021 161 उद्धरण
Current nutrition reports 2019 310 उद्धरण
Nutricion hospitalaria 2019 40 उद्धरण
American family physician 2018 101 उद्धरण
Pharmacological research 2018 67 उद्धरण
Nutricion hospitalaria 2018 32 उद्धरण
Frontiers in psychology 2018 13 उद्धरण
Advances in nutrition … 2017 215 उद्धरण
Annals of the … 2016 89 उद्धरण
Nutricion hospitalaria 2014 17 उद्धरण
Advances in nutrition … 2013 155 उद्धरण
Current treatment options … 2011 6 उद्धरण
Molecular neurobiology 2010 145 उद्धरण
Women's health (London, … 2010 48 उद्धरण
JAMA 2010 3 उद्धरण
The Practitioner 2010
The Cochrane database … 2009 299 उद्धरण
Prostaglandins, leukotrienes, and … 2009 258 उद्धरण
Neuro endocrinology letters 2008
The Cochrane database … 2007 375 उद्धरण
Prostaglandins, leukotrienes, and … 2006 176 उद्धरण
Medecine sciences : … 2005 19 उद्धरण
The Cochrane database … 2003 263 उद्धरण
Journal of Alzheimer's … 2003 161 उद्धरण
Pharmacological research 1999 1060 उद्धरण
Alternative medicine review … 1999 112 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
1,000-2,000 mg combined DHA/EPA per day
cognitivesupport:
1,000-1,700 mg/day (optimal dose-response curve)

अधिकतम सीमा: 3,000 mg/day combined DHA/EPA (FDA GRAS)

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None -- Mixed --
None -- Mixed --
Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
Vit D 1 mcg/kg + N-3 PUFA 300 mg/kg EPA+DHA 4 weeks Positive 50
None -- Mixed --

सेवन का सर्वोत्तम समय: With meals containing fat for better absorption

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Fishy aftertaste or burping
  • Mild gastrointestinal discomfort
  • Potential increased bleeding time at very high doses
  • May lower blood pressure slightly

ज्ञात अंतःक्रियाएँ

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
  • Blood pressure medications (additive hypotensive effect)
  • Orlistat (may reduce omega-3 absorption)

सहनीय अधिकतम सेवन: 3,000 mg/day combined DHA/EPA (FDA GRAS)

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Omega-3 Fatty Acids (DHA/EPA) help with Age-Related Cognitive Decline?
Based on 58 studies with 12,000 participants, there is strong evidence from multiple clinical trials that Omega-3 Fatty Acids (DHA/EPA) may support Age-Related Cognitive Decline management. Our evidence grade is A (Strong Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Age-Related Cognitive Decline?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 58 peer-reviewed studies with 12,000 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Age-Related Cognitive Decline

Omega-3 Fatty Acids (DHA/EPA) अन्य स्वास्थ्य स्थितियों के लिए

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।